Lab Information

Todd Lee (MD)

Scientist
Clinical Research Unit
Department of Medicine (McGill)

Research Profile

 Fundamental: 30%
 Clinical: 40%
 Epidemiology: 0%
 Evaluation: 30%
 This email address is being protected from spambots. You need JavaScript enabled to view it.
 https://www.drtoddlee.com/

Keywords

Quality improvement • patient safety • high value healthcare • antibiotic stewardship • polypharmacy

Research Interests

My research focuses on conducting randomized clinical trials designed to improve the treatment of infectious diseases (e.g., C. difficile, COVID-19, S. aureus, Gram-Negative infections) and to innovate in the domains of care of complex hospitalized patients, care of older adults with polypharmacy, and stewardship of healthcare resources (e.g., testing, medications).


Team Members

Name Position

Latest Publications

  1. Spellberg, B., Ghanem, B., Russell, C. D., So, M., Kang, M., Forrest, G., Cabanilla, M. G., Donovan, R., Whitehouse, M., Yen, C., Tong, S. Y. C., Ahn, J., Minejima, E., Davar, K., Tucker, C., Footer, B., Lee, R., Wald-Dickler, N., McDonald, M. E. G., Lee, T. C. & WikiGuidelines Group (2025). 2025 Update to WikiGuidelines for the Management of Pyogenic Osteomyelitis in Adults. The American journal of medicine.
  2. Prosty, C., Lee, T. C. & McDonald, E. G. (2025). Antibiotic Prophylaxis in Patients With Cirrhosis Presenting With Variceal Bleeding-Are We Treating the Past?-Reply. JAMA internal medicine.
  3. Lee, J. J., Filosa, E., Pierson, T., Khuong, N., Gagnon, C., Herbin, J., Rej, S., Godard-Sebillotte, C., Tamblyn, R., Lee, T. C. & McDonald, E. G. (2025). Assessing the acceptability and usability of MedSafer, a patient-centered electronic deprescribing tool. JAMIA open, vol. 8, p. ooaf141.
  4. Spellberg, B., Wald-Dickler, N., Holtom, P., Meyer-Sautter, P., Camp, A., Diaz, A. D., Buhamad, R., Vazquez, A. S. M., Aguirre-Garcia, G. M., Stanton, M., Butler-Wu, S. M., Chiu, I., Ergenc, Z., Bhoojhawon, G., Murri, R., Maraolo, A. E., Cabanilla, G., Riccardi, N., Tshisevhe, V., Behenna, C., Williams, K. S., Kufel, W. D., Wojciaczyk, N., Pimentel, B. V., Muyidi, A., Costa, R. P. L., Motta, F., Bortolussi-Courval, É., Lee, T. C., McDonald, E. G., Ghanem, B. & Nelson, Z. (2025). Reply to Datta, "Is static or cidal antibiotic falsifiable?". Antimicrobial agents and chemotherapy, p. e0139125.
  5. Deas, G., Lee, T. C., Colston, J., Albur, M., Vasant, J., Nobbs, A. H., Williams, P. & Hamilton, F. (2025). Streptococcal endocarditis: a meta-analysis of species dependant risk. EClinicalMedicine, vol. 87, p. 103425.
  6. Mellett, M., Van Riel, J., Corsini, R., Satola, S., Lawandi, A., Caya, C., van Hal, S., Lee, T. C., Papenburg, J., Yansouni, C. P., Babiker, A. & Cheng, M. P. (2025). The combinations of cefazolin with linezolid and cefazolin with clindamycin are indifferent against methicillin-susceptible Staphylococcus aureus. Microbiology spectrum, p. e0176325.
  7. Aw, M., Lee, T. C., Mendel, A. & Colmegna, I. (2025). Parvovirus B19-Associated Large-Vessel Vasculitis in an Immunocompromised Patient. The Journal of rheumatology.
  8. Turner, N. A., Hamasaki, T., Doernberg, S. B., Lodise, T. P., King, H. A., Ghazaryan, V., Cosgrove, S. E., Jenkins, T. C., Liu, C., Sharma, S., Zaharoff, S., Wahid, L., Renard, V. J., Cook, P., Raad, I., Hachem, R., Chaftari, A.-M., Sims, M., DeMarco, C., Miller, L. G., McCarthy, M. W., Morse, C. G., Lucasti, C., Forrest, G. N., Cherabuddi, K., Polk, C., Fazili, T., Rupp, M. E., Thompson, G. R., Kim, K., Strnad, L., Schnee, A. E., McKinnell, J. A., Ramesh, M., Silveira, F. P., McCarty, T. P., Lee, T. C., McDonald, E. G., Paolino, K., Wiegand, K., Wall, A., Riccobene, T., Patel, R., Rappo, U., Evans, S., Chambers, H. F., Fowler, V. G., Holland, T. L. & Antibacterial Resistance Leadership Group (2025). Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial. JAMA.
  9. Prosty, C., Noutsios, D., Dubé, L.-R., Baden, R., Davar, K., Freling, S., Bhuket, T., Yee, H. F., Spellberg, B., McDonald, E. G. & Lee, T. C. (2025). Prophylactic Antibiotics for Upper Gastrointestinal Bleeding in Patients With Cirrhosis: A Systematic Review and Bayesian Meta-Analysis. JAMA internal medicine, vol. 185, p. 1194-1203.
  10. Hosseini, B., Condon, A., da Costa, B. R., Daley, P., Greiver, M., Jüni, P., Lee, T. C., McBrien, K., McDonald, E. G., Murthy, S., Selby, P., Andrew, M., Aubrey-Bassler, K., Barber, D., Barrett, B., Butler, C. C., Crampton, N., Dahrouge, S., Damji, A., Fowler, R., Garies, S., Hudon, C., Hulme, J., Isenor, J., Jenkins, D. J. A., Lall, R., LeBlanc, A., Leong, C., Little, P., Lofters, A., Logsetty, S., Lother, S., Lussier, M.-T., Maclaren, L., Mangin, D., Marshall, E. G., Marshall, J. C., McCracken, R., Moineddin, R., Orava, B., Paquette, J.-S., Park, J. J. H., Persaud, N., Rac, V. E., Ramsden, V. R., Rayner, J., Sanchez-Ramirez, D. C., Saxinger, L., Shi, H., Singer, A., Spiwak, R., Srivastava, A., Sud, A., Tarride, J.-E., Telner, D., Upshur, R. E. G., Walji, S., Walsh, R., Wilchesky, M., Wong, S. T., Wood, B., Zarychanski, R., Zelek, B., Keynan, Y., Piszczek, J., Warshafsky, D. & Pinto, A. D. (2025). Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID): protocol for a randomised controlled adaptive platform trial of treatments for acute SARS-CoV-2 infection in community settings. BMJ open, vol. 15, p. e097134.
More on PubMed 



See also

Card image
Emily
McDonald


See profile
Card image
Matthew
Cheng


See profile
Card image
Alexander
Lawandi


See profile
Card image
Donald
Vinh


See profile
Card image
Cédric
Yansouni


See profile
Card image
Jesse
Papenburg


See profile